Apparently, psychedelic shroom experiences are the key to quitting smoking


Coffee breaks, car rides, drinks with friends—all have become high-wires forcing participation in a game of mental acrobatics. I’m sitting at my desk chewing on the back of a plastic pen. My co-worker has a sickening smirk plastered across his heartless face as he dangles a cigarette in front of me like a carrot as he walks to the elevator. That bastard knows this is my third time trying to quit smoking. But according to a study by Johns Hopkins University, quitting smoking doesn’t have to be self-induced misery.

2_the key to quitting smoking

According to Johns Hopkins University, the road to quitting smoking might not be paved with nicotine patches, but rather lined with something a little more fun—magic mushrooms.

3_the key to quitting smoking

After being given incremental doses of psilocybin pellets, 80 per cent of study participants had not touched a cigarette in 6 months.

4_the key to quitting smoking

Fifteen people participated in the study—five women and ten men. On average, participants smoked 19 cigarettes a day for over three decades. Most participants had never used psychedelic substances before and those that had had at least 27 years between their last trip experience.

Compare this to Nicotine replacement therapy—like gum and the patch— which has an 8.2 per cent success rate according to The American Journal of Public Health.

5_the key to quitting smoking

Currently the most successful prescription alternative is varenicline, a drug that has side effects including headaches, stomach pain, irregular heartbeat, feelings of sadness or emptiness and in some cases, suicidal thoughts. Its success rate is also only 35 per cent.

While the staggering success rate has caused some huge excitement, the authors of the study were careful to note that in no way is this encouragement for smokers everywhere to find their nearest dreadlocked hippie drug dealer so they can go on a psychedelic nature walk to nicotine-sobriety. Rather, the psilocybin was administered in multiple sessions in a controlled clinical setting and complemented by cognitive behaviour therapy.

But nevertheless this could mean big things for the use of the legal status of psilocybin mushrooms. Currently magic mushrooms are classified as Schedule One according to the DEA, meaning the drug has “no potential medical benefits” and that production or possession is a Class 1 federal felony. With the new study by Johns Hopkins University on the benefits of psilocybin mushrooms at alleviating addiction, a petition for their reclassification might be in order.

Researchers believe that the psychoactive effects of psilocybin are so effective at breaking addiction because they force users to observe their behaviour from a different perspective, allowing them to reflect on their addiction and break deep-rooted behaviours and thoughts.

6_the key to quitting smoking

Leave a Reply

Your email address will not be published. Required fields are marked *